Characteristics | Antibiotic prescriptions n (%) | Crude OR (95% CI) | P | Adjusted ORa (95% CI) | P |
---|---|---|---|---|---|
Patient-related factors | |||||
 Age (years) | |||||
  0–4 | 294 (32.1) | 1 |  | 1 |  |
  5–9 | 187 (28.2) | 0.83 (0.67–1.04) | 0.10 | 0.81 (0.65–1.02) | 0.07 |
  10–14 | 71 (23.2) | 0.64 (0.47–0.86) | 0.003 | 0.62 (0.46–0.85) | 0.002 |
  15–17 | 42 (33.9) | 1.08 (0.73–1.61) | 0.70 | 1.10 (0.73–1.66) | 0.64 |
 Sex | |||||
  Boys | 295 (28.6) | 1 |  | 1 |  |
  Girls | 309 (31.3) | 1.12 (0.93–1.36) | 0.23 | 1.16 (0.96–1.41) | 0.14 |
 Duration of symptoms (days) | |||||
  1 | 22 (22.2) | 1 |  | 1 |  |
  2 | 152 (25.0) | 1.17 (0.70–1.94) | 0.55 | 1.08 (0.64–1.81) | 0.78 |
  3 | 223 (33.1) | 1.73 (1.05–2.85) | 0.03 | 1.53 (0.91–2.57) | 0.11 |
  4 | 137 (32.6) | 1.69 (1.01–2.84) | 0.045 | 1.57 (0.92–2.68) | 0.10 |
  5 | 73 (30.5) | 1.54 (0.89–2.66) | 0.12 | 1.50 (0.84–2.65) | 0.17 |
FP-related factors | |||||
 Age (years) | |||||
  30–40 | 89 (25.2) | 1 |  | 1 |  |
  41–50 | 172 (36.1) | 1.67 (1.23–2.27) | 0.001 | 1.76 (1.24–2.51) | 0.002 |
  51–60 | 167 (25.7) | 1.02 (0.76–1.38) | 0.88 | 0.96 (0.69–1.32) | 0.79 |
  61+ | 179 (32.1) | 1.40 (1.04–1.89) | 0.03 | 1.12 (0.80–1.57) | 0.52 |
 Sex | |||||
  Male | 15 (32.6) | 1 |  | 1 |  |
  Female | 529 (29.7) | 0.87 (0.47–1.63) | 0.67 | 0.92 (0.47–1.80) | 0.81 |
 Work experience | |||||
   < 5 years | 48 (25.7) | 1 |  | 1 |  |
  6–10 years | 15 (14.6) | 0.49 (0.26–0.94) | 0.03 | 0.70 (0.35–1.41) | 0.32 |
  11–20 years | 106 (31.4) | 1.32 (0.89–1.98) | 0.17 | 1.52 (0.96–2.41) | 0.08 |
  21+ years | 438 (31.0) | 1.30 (0.92–1.84) | 0.13 | 1.28 (0.87–1.86) | 0.21 |
 Location of practice | |||||
  Rural areas | 246 (33.0) | 1.28 (1.04–1.59) | 0.02 | 1.42 (1.10–1.84) | 0.01 |
  Regional cities | 119 (28.3) | 1.03 (0.80–1.34) | 0.82 | 1.23 (0.92–1.65) | 0.16 |
  Capital of Latvia | 242 (27.7) | 1 |  | 1 |  |
 Number of paediatric patients in practice | |||||
   < 500 | 266 (25.6) | 1 |  | 1 |  |
  501–1000 | 267 (34.7) | 1.54 (1.26–1.89) | < 0.001 | 1.68 (1.33–2.11) | < 0.001 |
  1001+ | 74 (31.9) | 1.36 (1.26–1.89) | 0.05 | 1.59 (1.09–2.34) | 0.02 |
 Study group | |||||
  Intervention | 320 (27.8) | 0.80 (0.66–0.97) | 0.02 | 0.83 (0.67–1.03) | 0.09 |
  Control | 287 (32.4) | 1 |  | 1 |  |